---
title: "688050.SH (688050.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688050.SH/news.md"
symbol: "688050.SH"
name: "688050.SH"
parent: "https://longbridge.com/en/quote/688050.SH.md"
datetime: "2026-05-21T03:24:39.022Z"
locales:
  - [en](https://longbridge.com/en/quote/688050.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688050.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688050.SH/news.md)
---

# 688050.SH (688050.SH) — Related News

### [Eyebright Medical announced the 2025 annual report and sustainability report](https://longbridge.com/en/news/284138948.md)
*2026-04-27T02:01:28.000Z*
> Eyebright Medical announced its 2025 annual report and sustainability report, showing an operating revenue of RMB 1.483 

### [Eyebright Medical: Net profit of 89.2768 million yuan in the first quarter of 2026, a year-on-year decrease of 3.55%](https://longbridge.com/en/news/283671106.md)
*2026-04-22T13:01:07.000Z*
> Eyebright Medical announced that its operating revenue for the first quarter of 2026 was 398 million yuan, a year-on-yea

### [Eyebright Medical has established its Asia-Pacific headquarters in Singapore, with the regional market becoming increasingly important for the group's growth | Lianhe Zaobao](https://longbridge.com/en/news/281005194.md)
*2026-03-30T11:02:17.000Z*
> The German medical technology company Eyebright Medical has established its Asia-Pacific headquarters in Singapore to ce

### [Eyebright Medical shareholder Mao Liping plans to reduce holdings by no more than 1%](https://longbridge.com/en/news/279585480.md)
*2026-03-18T11:19:06.000Z*
> According to the Zhitong Finance APP, Eyebright Medical announced that shareholder Mr. Mao Liping plans to reduce his ho

### [Young people after myopia surgery are supporting a new industry, as leading ophthalmology companies collectively bet on the once "most miserable" orthopedic track ｜ Cross-industry inquiry](https://longbridge.com/en/news/278201655.md)
*2026-03-06T09:04:15.000Z*
> As young people participate in sports after undergoing myopia surgery, leading ophthalmology companies such as Eyebright

### [Eyebright Medical: Net profit of 265 million yuan in 2025, a year-on-year decrease of 31.67%](https://longbridge.com/en/news/277165651.md)
*2026-02-27T08:38:15.000Z*
> Eyebright Medical announced that it achieved a total operating revenue of 1.483 billion yuan in 2025, a year-on-year inc

### [A premium of over three times, an additional 500 million yuan in goodwill, Eyebright Medical bets on Demei Medical](https://longbridge.com/en/news/277064378.md)
*2026-02-26T08:15:09.000Z*
> Eyebright Medical (688050) plans to acquire a 68.31% stake in Demei Medical for 683 million yuan, with a transaction pre

### [Aito encounters bottlenecks in its ophthalmology main business, Eyebright Medical invests 683 million yuan to cross into sports medicine](https://longbridge.com/en/news/276999658.md)
*2026-02-26T07:25:15.000Z*
> Eyebright Medical plans to acquire 68.31% equity of Demei Medical for 683 million yuan due to growth bottlenecks in its